BNR
Burning Rock Biotech Ltd
15.20$
-5.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
Burning Rock Biotech Ltd (BNR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -22 million CNY. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -31 | -106 | -55 | -17 | -50 | -7.0 | 61 | -37 | -91 | -113 | -119 | -133 | -112 | -144 | -109 | -135 | -68 | -113 | -79 | -47 | -16 | -40 | -41 | -30 | 19 | -24 | -44 | 16 | 23 | -29 | -22 | -12 | |
| 5.7 | 7.0 | – | – | 31 | 7.7 | 32 | 26 | 26 | 22 | 22 | 48 | 48 | 48 | 60 | 124 | 124 | 124 | – | 131 | 131 | 131 | – | – | – | 52 | – | – | – | 22 | – | – | |
| 1.5 | 1.7 | – | 3.3 | 23 | 4.2 | 28 | 69 | 169 | 85 | 83 | 54 | 282 | 80 | 77 | 78 | 327 | 78 | 38 | 73 | 71 | 69 | 68 | 10 | – | 4.5 | 2.4 | – | – | 1.8 | – | – | |
| – | 8.3 | -29 | 15 | – | 4.6 | 132 | 90 | -80 | 58 | 85 | 37 | 139 | 117 | 153 | 96 | 36 | 72 | 52 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 19 | -105 | – | – | -120 | 33 | – | -33 | -33 | -101 | -101 | -21 | -21 | -21 | – | 6.3 | -33 | 6.3 | – | -4.4 | -4.4 | -4.4 | – | – | – | -42 | – | – | – | -59 | – | – | |
| 6.0 | 6.4 | 0.0 | 0.0 | 45 | 3.6 | 76 | 57 | 57 | 105 | 105 | 204 | 204 | 204 | 43 | 62 | 62 | 62 | 0.0 | 8.1 | 8.1 | 8.1 | 0.0 | 0.0 | 0.0 | 5.4 | 0.0 | 0.0 | 0.0 | 5.2 | 0.0 | 5.2 | |
| -6.0 | -175 | -168 | -26 | 22 | -3.6 | 296 | -365 | -36 | 288 | -68 | -72 | -67 | -13 | 31 | -20 | -5.0 | -4.1 | -2.9 | -2.0 | -0.3 | -2.4 | -0.2 | -1.0 | – | -1.5 | 0.2 | -2.7 | – | -0.4 | -2.5 | – | |
| – | -0.4 | – | – | -3.6 | 0.0 | – | – | – | -4.3 | -4.3 | -4.3 | -4.3 | – | – | -72 | -72 | -72 | – | -7.0 | -7.0 | -7.0 | – | – | – | -0.1 | – | – | – | – | – | – | |
| – | -5.7 | 2.3 | 2.3 | – | 2.3 | -21 | -21 | -21 | -45 | -45 | -45 | -45 | – | – | -2.4 | -2.4 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 20 | 590 | 3.1 | -23 | 1.1 | 272 | 1,846 | -21 | 68 | -4.2 | -9.0 | -33 | -6.8 | -3.9 | -70 | -2.7 | -10 | 0.0 | -1.0 | -46 | -1.9 | -1.9 | – | 0.0 | – | -0.1 | 2.0 | – | – | -0.1 | -0.1 | – | |
| -15 | 313 | -222 | -60 | -27 | 266 | 2,202 | -504 | -137 | 188 | -230 | -234 | -211 | -164 | -122 | -139 | -89 | -122 | -70 | -97 | -22 | -43 | -40 | -35 | 24 | -25 | -42 | 12 | 14 | -32 | -30 | -36 | |
| -37 | -112 | -55 | -17 | -95 | -11 | 61 | -37 | -147 | -113 | -224 | -133 | -317 | -144 | -109 | -135 | -130 | -113 | -79 | -47 | -24 | -40 | -41 | -30 | 13 | -24 | -44 | 16 | 18 | -29 | -22 | -17 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.